Complete profile


Third-Party Information Liability Disclaimer

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.




Last Updated: 2013-01-07

Sandoz Canada Inc.

Company information

 
 
Legal Name:   Sandoz Canada Inc.
Operating Name:   Sandoz Canada Inc.
 
Mailing Address
145, rue Jules-Leger
BOUCHERVILLE, Quebec
J4B 7K8
Location Address
145, rue Jules-Leger
BOUCHERVILLE, Quebec
J4B 7K8
 
Telephone: (450) 641-4903
Toll Free Phone: 1-800-343-8839
Fax: (514) 596-1460
Email: deborah-ann.bourgeois@sandoz.com
Website URL: http://www.sandoz.ca 
 
Top

Contact information

 
Michel Saucier, Ph. D.Pharm
  Title:   President
  Area of Responsibility:   Management Executive
  Telephone:   (450) 641-4903
  Ext:   2135
  Fax:   (450) 641-8615
  Email:   m.saucier@sabex-inc.com
 
 
Christine Woolgar
  Title:   Vice President
  Area of Responsibility:   Finance/Accounting
  Telephone:   (450) 641-4903
  Ext:   2132
  Fax:   (514) 596-1460
  Email:   s.lefevre@sabex-inc.com
 
 
Pierre Fréchette
  Title:   President
  Telephone:   (450) 641-4903
  Fax:   (514) 596-1460
  Email:   pierre.frechette@sabex.ca
 

Top

Company description

 
Country of Ownership: Foreign  
Year Established: 1980
Exporting: Yes  
Primary Industry (NAICS): 325410 - Pharmaceutical and Medicine Manufacturing
Primary Business Activity: Manufacturer / Processor / Producer  
Total Sales ($CDN): $50,000,000 + 
Export Sales ($CDN): $10,000,000 to $24,999,999 
Number of Employees: 400 

Top

Product / Service / Licensing

 
Product Name: ANALGESICS, NARCOTIC TYPE, IN DOSAGE, NES
 
 
Product Name: ANALGESICS, NON-NARCOTIC, DOSAGE, HUMAN, NES
 
 
Product Name: ANTACIDS NES, IN DOSAGE
 
 
Product Name: ANTISEPTICS, MEDICINAL, RETAIL PKG, HUMAN NES
 
 
Product Name: ATROPINE, IN DOSAGE, HUMAN USE
 
 
Product Name: CALCIUM THERAPY PREPS, IN DOSAGE, HUMAN USE
 
 
Product Name: CHLORPROMAZINE, IN DOSAGE, HUMAN USE
 
 
Product Name: CODEINE PHOSPHATE, IN DOSAGE
 
 
Product Name: DEXAMETHASONE, IN DOSAGE, HUMAN USE
 
 
Product Name: DIAZEPAM, IN DOSAGE
 
 
Product Name: DICYCLOMINE HCL, IN DOSAGE
 
 
Product Name: DIMENHYDRINATE, IN DOSAGE, HUMAN USE
 
 
Product Name: DIPHENHYDRAMINE, IN DOSAGE, HUMAN USE
 
 
Product Name: FOLIC ACID, IN DOSAGE, HUMAN USE
 
 
Product Name: FUROSEMIDE, IN DOSAGE
 
 
Product Name: HALOPERIDOL, IN DOSAGE
 
 
Product Name: HYDROXYZINE, IN DOSAGE
 
 
Product Name: LAXATIVES NES, IN DOSAGE, HUMAN USE
 
 
Product Name: MAGNESIUM SULPHATE, IN DOSAGE, HUMAN USE
 
 
Product Name: MEPERIDINE HYDROCHLORIDE, DOSAGE, HUMAN USE
 
 
Product Name: MORPHINE SULPHATE, IN DOSAGE
 
 
Product Name: MULTIVITAMIN PREPARATIONS, DOSAGE, HUMAN USE
 
 
Product Name: OPHTHALMICS, IN DOSAGE, HUMAN USE, NES
 
 
Product Name: PENTOBARBITAL SODIUM, IN DOSAGE, HUMAN USE
 
 
Product Name: PHARMACEUTICAL PRODS NES, DOSAGE, HUMAN USE
 
 
Product Name: PROCHLORPERAZINE, IN DOSAGE
 
 
Product Name: PROMETHAZINE, IN DOSAGE, HUMAN USE
 
 
Product Name: SEDATIVES & TRANQUILIZERS, DOSAGE, HUMAN, NES
 
 
Product Name: SODIUM BICARBONATE, IN DOSAGE, HUMAN USE
 
 
Product Name: THIAMINE, IN DOSAGE, HUMAN USE
 
 
Product Name: VITAMIN B-12, IN DOSAGE, HUMAN USE
 
 
Product Name: VITAMIN C, IN DOSAGE, HUMAN USE
 
 
Product Name: VITAMIN K, IN DOSAGE, HUMAN USE
 
 

Top

Market profile

Alliances:

  • Financial
  • Sales/Marketing
  • Technology

Geographic markets:

Export experience:
  • Algeria
  • Brazil
  • Costa Rica
  • Cuba
  • Jamaica
  • Japan
  • Mexico
  • Nicaragua
  • Nigeria
  • United States
  • Zambia
  • California
  • Florida
Actively pursuing:
  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • Colorado
  • Connecticut
  • Delaware
  • District of Columbia
  • Georgia
  • Hawaii
  • Idaho
  • Illinois
  • Indiana
  • Iowa
  • Kansas
  • Kentucky
  • Louisiana
  • Maine
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Mississippi
  • Missouri
  • Montana
  • Nebraska
  • Nevada
  • New Hampshire
  • New Jersey
  • New Mexico
  • New York
  • North Carolina
  • North Dakota
  • Ohio
  • Oklahoma
  • Oregon
  • Pennsylvania
  • Rhode Island
  • South Carolina
  • South Dakota
  • Tennessee
  • Texas
  • Utah
  • Vermont
  • Virginia
  • Washington
  • West Virginia
  • Wisconsin
  • Wyoming

Top



Note: This document is presented in the language provided by the author/source. Most of the information contained in Canadian Company Capabilities (CCC) has been provided by sources external to Industry Canada. The accuracy, currency and reliability of the information contained in CCC are the sole responsibility of the registered companies and related organizations. Industry Canada assumes no responsibility in this respect. The registered businesses shall ensure the continued monitoring of the information contained in CCC and ask that it be modified when necessary.